These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 110445)

  • 21. Toxic cardiomyopathies.
    Balazs T; Herman EH
    Ann Clin Lab Sci; 1976; 6(6):467-76. PubMed ID: 793502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effect of melatonin on adriamycin-induced acute cardiac injury.
    Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S
    Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
    Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
    J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
    Alderton P; Gross J; Green MD
    Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury.
    Gabrielson K; Bedja D; Pin S; Tsao A; Gama L; Yuan B; Muratore N
    Cancer Res; 2007 Feb; 67(4):1436-41. PubMed ID: 17308081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
    Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamin E against adriamycin-induced toxicity in rabbits.
    Wang YM; Madanat FF; Kimball JC; Gleiser CA; Ali MK; Kaufman MW; van Eys J
    Cancer Res; 1980 Apr; 40(4):1022-7. PubMed ID: 7357532
    [No Abstract]   [Full Text] [Related]  

  • 28. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity.
    Cole MP; Chaiswing L; Oberley TD; Edelmann SE; Piascik MT; Lin SM; Kiningham KK; St Clair DK
    Cardiovasc Res; 2006 Jan; 69(1):186-97. PubMed ID: 16157314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
    Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
    Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic cardiotoxicity of adriamycin and the possible prevention by coenzyme Q10 in rabbits (author's transl)].
    Sawada H; Tashima M; Donomae N; Eguchi T; Uehara N; Shirakawa S; Yamagishi M; Nakamura T; Uchino H; Konishi T; Okazaki H; Matsuyama E
    Nihon Gan Chiryo Gakkai Shi; 1979 Apr; 14(2):143-51. PubMed ID: 448221
    [No Abstract]   [Full Text] [Related]  

  • 33. R-wave voltage in the right precordial leads in anthracycline cardiomyopathy: experimental animal model.
    Onouchi Z; Tamiya H; Sakakibara Y; Ando M; Fujimoto T
    Int J Tissue React; 1988; 10(1):45-51. PubMed ID: 3397252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the cardiotoxicity of adriamycin and aclacinomycin A in the rat. Optical and electron microscopic study].
    Bouhour JB; Delajartre AY; Chiffoleau S; Fumoleau P; Nicolas G
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1270-6. PubMed ID: 6419694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
    Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
    Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related acute adriamycin cardiotoxicity in mice.
    Matsumura M; Nishioka K; Fujii T; Yoshibayashi M; Nozaki K; Nakata Y; Temma S; Ueda T; Mikawa H
    J Mol Cell Cardiol; 1994 Jul; 26(7):899-905. PubMed ID: 7966358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model.
    Panjrath GS; Patel V; Valdiviezo CI; Narula N; Narula J; Jain D
    J Am Coll Cardiol; 2007 Jun; 49(25):2457-64. PubMed ID: 17599610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in mice.
    Hermansen K; Wassermann K
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):31-7. PubMed ID: 3953291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined cardiotoxicity of adriamycin and x-radiation.
    Fajardo LF; Eltringham JR; Steward JR
    Lab Invest; 1976 Jan; 34(1):86-96. PubMed ID: 1246126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.